CD44 is required for two consecutive steps in HGF/c-Met signaling

  1. Véronique Orian-Rousseau,
  2. Linfeng Chen,
  3. Jonathan P. Sleeman,
  4. Peter Herrlich, and
  5. Helmut Ponta1
  1. Forschungszentrum Karlsruhe, Institute of Toxicology and Genetics, D-76021 Karlsruhe, Germany

Abstract

The tyrosine kinase receptor c-Met and its ligand HGF/SF, ezrin, and splice variants of CD44 have independently been identified as tumor metastasis-associated proteins. We now show that these proteins cooperate. A CD44 isoform containing variant exon v6 sequences is strictly required for c-Met activation by HGF/SF in rat and human carcinoma cells, in established cell lines as well as in primary keratinocytes. CD44v6-deficient tumor cells were unable to activate c-Met unless they were transfected with a CD44v6-bearing isoform. Antibodies to two v6-encoded epitopes inhibited autophosphorylation of c-Met by interfering with the formation of a complex formed by c-Met, CD44v6, and HGF/SF. In addition, signal transduction from activated c-Met to MEK and Erk required the presence of the cytoplasmic tail of CD44 including a binding motif for ERM proteins. This suggests a role for ERM proteins and possibly their link to the cortical actin cytoskeleton in signal transfer.

Keywords

Footnotes

  • 1 Corresponding author.

  • E-MAIL genetik{at}itg.fzk.de; FAX 49-7247-823354.

  • Supplemental material is available online at http://www.genesdev.org.

  • Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/gad.242602.

    • Received July 19, 2002.
    • Accepted October 4, 2002.
| Table of Contents

Life Science Alliance